An oral anticonvulsant medication used in combination with other medication and therapy to treat Lennox–Gastaut syndrome and various other seizure disorders.
Rufinamide, a triazole derivative, approved as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in children 4 years and older and adults.
The drug has efficacy for partial seizures.
Brand name Banzel.
The mechanism of action is unknown.
Can modulate the gating of voltage-gated sodium channels, a common target for antiepileptic drugs.